Concepedia

Publication | Open Access

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS

DOIFull Paper Access

81

Citations

36

References

2015

Year

Heather B. Streeter, Rachel Rigden, Keith F. Martin, Neil Scolding, David C. Wraith
Neurology Neuroimmunology & Neuroinflammation

Abstract

This study provides Class IV evidence that ATX-MS-1467 is safe and tolerated in a group of 6 patients with SPMS.

References

YearCitations

Page 1